Diego A. Díaz García: Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Diego A. Díaz García, Medical Oncologist / CEO / Founder at CánCare – Advanced Specialty in Oncology, shared a post on X:
“Survival of patients with Lung Adenocarcinoma diagnosed in 2000, 2010, and 2020.
Median OS in lung adenocarcinoma more than doubled in 20 years (8.5 → 20.7 months) in non-academic public hospitals in France.
Targeted therapy and immunotherapy significantly improved outcomes, even outside academic centers.”
Title: Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Journal: NEJM Evidence
Authors: Didier Debieuvre, Lionel Falchero, Olivier Molinier, Sébastien Couraud, Alexis Cortot, Nicolas Meyer, Bernard Asselain, Etienne Auvray, Dorine Templement-Grangerat, Acya Bizieux, Jean Tredaniel, Sophie Schneider, Jean-Bernard Auliac, Olivier Bylicki, Alexia Letierce, Hugues Morel
More posts featuring Diego A. Díaz García on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023